Abstract: The invention encompasses biodegradable compositions (e.g., biodegradable plastics) and methods of preparation and use thereof, and disposable products made from the claimed compositions. Raw materials for preparing the biodegradable plastic include one or more polymers, fiber, starch, a plasticizer, and a coupling agent. The biodegradable composition has the advantages of short degradation cycle, good mechanical properties, and a low manufacturing cost.

Abstract: A sensor may include a sensing element retained within a storage compartment filled with a storage medium, which may also be used as a calibration medium. The sensing element can include a sensing surface located away from the distal end of the sensing element, such that an inactive section of the sensing element can cooperate with a sealing member such as an O-ring to form part of the seal retaining the storage/calibration medium. The sensing element can be extended and retracted from the storage compartment to expose the sensing surface to a process medium, while preserving the storage medium within the storage compartment for post-measurement validation.

Abstract: Certain aspects of the present disclosure provide techniques for securely accessing a wallet on a blockchain. An example method generally includes receiving a request to access a wallet on a blockchain. The request generally includes an authorization code associated with the wallet and user credentials associated with an owner of the wallet. A first portion of a private key is decrypted based on the authorization code and a salt associated with the user credentials, and a second portion of the private key is decrypted based on credentials associated with an application through which the wallet is accessed. Access to the wallet is granted based on the decrypted first portion and the decrypted second portion of the private key.

Abstract: A sensor may include a sensing element retained within a storage compartment filled with a storage medium, which may also be used as a calibration medium. The sensing element can be moved from a first position in which the sensing element is exposed to the storage compartment, and a second position in which the sensing element can be exposed to a process medium. An actuator mechanism may be configured to engage a portion of the sensor to move the sensing element between the first position and the second position. The actuator mechanism may be controlled by an external system, and may include a rotary actuator such as a servomotor or a stepper motor to move the sensing element between the first position and the second position.

Abstract: Disclosed is an oral drug delivery device, comprising a tubular member, a drug holding part, a device cap and a turbulence-creating means. The tubular member has openings at both ends and an inner cavity; the opening at one end is a first opening and the opening at the other end is a second opening; the inner cavity communicates the first opening and the second opening. The turbulence-creating means comprises a step structure or a fold structure, and is disposed in the inner cavity and positioned between the second opening and the drug holding part. By using the oral drug delivery device of the present invention, turbulence can be generated during a normal sipping process, thereby providing ample mixing of drug-containing granules or multi-particulates with drinkable liquids. Moreover, the device is telescopic, which reduces the size and is convenient to carry.

Abstract: A sensor may include a sensing element retained within a storage compartment filled with a storage medium, which may also be used as a calibration medium. The sensing element can include a sensing surface located away from the distal end of the sensing element, such that an inactive section of the sensing element can cooperate with a sealing member such as an O-ring to form part of the seal retaining the storage/calibration medium. The sensing element can be extended and retracted from the storage compartment to expose the sensing surface to a process medium, while preserving the storage medium within the storage compartment for post-measurement validation.

Abstract: Provided are an artificial intelligence (AI) system using a machine learning algorithm such as deep learning, and applications thereof. A method, performed by an electronic apparatus, of processing images includes obtaining a plurality of training image sets corresponding to a plurality of types of target objects, wherein training images in the training image sets are labeled with feature points forming a preset structure, generating a first artificial intelligence (AI) model for determining a standard structure based on the labeled feature points, by using the training images in the training image sets, identifying a face in a training image transformed based on the standard structure, and training a second AI model for verifying the first AI model, based on an image regressed from the transformed training image, and the training image before being transformed.

Abstract: The present disclosure relates to an oral retention device and an osmotic pump tablet, preparation method therefor and application thereof. The medicinal tablet is inserted into the oral retention device to form a pharmaceutical device composition. The pharmaceutical device composition is fixed on the matching teeth in the oral cavity to achieve sustained release of the drug within a certain period of time. A high-dose osmotic pump tablet of the present disclosure with the absorption window of active pharmaceutical ingredients limited to the upper gastrointestinal tract has a high drug loading capacity and can achieve a good therapeutic effect.

Abstract: Provided are an artificial intelligence (AI) system using a machine learning algorithm such as deep learning, and applications thereof. A method, performed by an electronic apparatus, of processing images includes obtaining a plurality of training image sets corresponding to a plurality of types of target objects, wherein training images in the training image sets are labeled with feature points forming a preset structure, generating a first artificial intelligence (AI) model for determining a standard structure based on the labeled feature points, by using the training images in the training image sets, identifying a face in a training image transformed based on the standard structure, and training a second AI model for verifying the first AI model, based on an image regressed from the transformed training image, and the training image before being transformed.

Abstract: A sensor may include a sensing element retained within a storage compartment filled with a storage medium, which may also be used as a calibration medium. The sensing element can be moved from a first position in which the sensing element is exposed to the storage compartment, and a second position in which the sensing element can be exposed to a process medium. An actuator mechanism may be configured to engage a portion of the sensor to move the sensing element between the first position and the second position. The actuator mechanism may be controlled by an external system, and may include a rotary actuator such as a servomotor or a stepper motor to move the sensing element between the first position and the second position.

Abstract: Disclosed are a controlled-release dosage form with an absorption window in the upper gastrointestinal tract and a preparation method therefor, wherein the controlled-release dosage form comprises a controlled-release platform and a retention platform. The controlled-release platform is a pharmaceutical composition comprising a tablet core and a coating membrane; and the retention platform holds the controlled-release platform in the oral cavity. The operation steps of the controlled-release dosage form are as follows: placing the controlled-release platform in the retention platform, and fixing the retention platform on matching teeth in the oral cavity; taking out the controlled-release dosage form after 4-24 hours and replacing same with a new controlled-release platform; and re-fixing the retention platform on the matching teeth in the oral cavity to achieve the sustained and stable release of drugs.

Abstract: Disclosed is a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. The pharmaceutical composition comprises a pharmaceutically active ingredient, dabigatran etexilate and/or dabigatran etexilate mesylate, an amphiphilic polymer of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer, and a hydrophilic polymer of polyoxyethylene-polyoxypropylene glycol block copolymer. The mass percentage of the active pharmaceutical ingredient in the pharmaceutical composition is 5 wt % to 60 wt %; the mass percentage of the amphiphilic polymer in the pharmaceutical composition is 3 wt % to 40 wt %; and the mass percentage of the hydrophilic polymer in the pharmaceutical composition is 10 wt % to 90 wt %. The pharmaceutical composition not only increases the bioavailability of the pharmaceutically active ingredient, but also reduces absorption variability, and provides a more stable concentration of dabigatran in plasma, thereby reducing adverse side effects.

Abstract: A solid particle, a preparation method therefor, and a pharmaceutical composition. The solid particle comprises a porous solid particle and a non-aqueous liquid formula. The non-aqueous liquid formula comprises 0.10-4.00 wt % of a hydrophobic active pharmaceutical agent, 28.00-99.90 wt % of a hydrophobic solubilizing solution, 0-70.00 wt % of a non-ionic surfactant, and 0-1.00 wt % of an antioxidant. The hydrophobic solubilizing solution comprises a medium-chain monoglyceride and diglyceride, and/or a propylene glycol fatty acid monoester.

Abstract: Disclosed are a pharmaceutical composition, an osmotic pump controlled-release drug delivery system comprising the pharmaceutical composition and a preparation method therefor. The pharmaceutical composition comprises a tablet core and a coating film. The tablet core comprises a drug-pulling layer, and the coating film comprises 50-90 wt % of cellulose acetate and 10-50 wt % of Copovidone. The Copovidone can be obtained by means of the polymerization of vinyl pyrrolidone and vinyl acetate in a molar ratio of 40:60-80:20.

Abstract: Disclosed is a pharmaceutical composition containing dabigatran etexilate and a preparation method thereof. The pharmaceutical composition comprises a pharmaceutically active ingredient, dabigatran etexilate and/or dabigatran etexilate mesylate, and a amphiphilic polymer of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer. The mass ratio of the two is 1:0.23 to 1:3. The pharmaceutical composition not only increases the bioavailability of the pharmaceutically active ingredient, but also reduces absorption variability, and provides a more stable concentration of dabigatran in plasma, thereby reducing adverse side effects.

Abstract: The present invention relates to a noninvasive electrical stimulation method and device, and the noninvasive electrical stimulation method includes the steps of: arranging first and second electrodes for applying electrical stimulation to a human body and first and second magnetic materials to thus allow the first and second magnetic materials to generate a magnetic field in a direction crossing the direction of an electric current between the first and second electrodes; and controlling at least one of a crossing angle (?) at which the electric current between the first and second electrodes and the magnetic field generated by the first and second magnetic materials cross each other and the strength (B) of the magnetic field generated by the first and second magnetic materials.

Abstract: An apparatus and a method for the disclosure relates to an artificial intelligence (AI) system that simulates functions such as recognition and determination of the human brain by using a machine training algorithm such as deep learning and an application of the AI system are provided. A neural network training method includes obtaining target modality signals of a first domain aligned in a time order and auxiliary modality signals of a second domain that are not aligned in the time order, extracting characteristic information of the target modality signals using a first neural network model, estimating the time order of the auxiliary modality signals using a second neural network model, and training the first neural network model based on a result of the estimation and the characteristic information.

Abstract: A bioreactor sensing system is presented. The bioreactor sensing system comprises a bioreaction vessel. The bioreaction vessel comprises an aperture configured to provide an interface for monitoring contents within the bioreaction vessel. The bioreaction vessel also comprises a port coupled to the bioreaction vessel proximate the aperture. The bioreactor sensing system also comprises a sensing device disposed at least partially within the port such that a sensing element is exposed to the contents. The bioreactor sensing system also comprises an external seal configured to be applied over a portion of the sensing device and a portion of the port.

Abstract: The present disclosure discloses a method for making an ice surface of an ice rink and an ice rink including the ice surface. In the method, a salt solution is applied to an ice surface. The salt solution contains anions. A concentration of the anions is in a range from about 0.63 mmol/L to about 10 mmol/L. The anions in the salt solution are selected from the group consisting of chloride ions, nitrate ions, bromide ions, iodide ions, chlorate ions, perchlorate ions, thiocyanate ions, and any combination thereof. The ice surface is maintained at a temperature of about ?4° C. to about 14° C. to naturally freeze the salt solution.